Isomorphic Labs Expands Partnership with Novartis and Announces Collaboration with Johnson & Johnson
HIGHLIGHTS
- •Isomorphic Labs expanded partnership with Novartis and announced collaboration with Johnson & Johnson
- •Isomorphic Labs will include up to three additional research programs with Novartis and combine its AI-first drug design approach with Johnson & Johnson's drug discovery experience
- •To discover small molecule therapeutics against challenging targets and develop new therapeutics for historically challenging diseases
Published:
Official Source (Official Website)